Washington CannaBusiness Association
(WACA)

Director of Legislative Relations Chris Thompson described the status of cannabis-related bills, and the potential that cannabinoid request legislation would fail in part due to “misinformation.”

A definition of ‘impairing’ was added to legislation on cannabinoid regulation along with legislative oversight of WSLCB rulemaking before members recommended the bill be advanced.

Testimony on legislation to revise regulation of cannabinoids emphasized policy pitfalls versus prospective benefits, and hinted at fiscal fallout from litigious hemp industry interests.

After a brutal week for cannabis-related legislation which saw more than half rendered inactive, legislators prepared to undertake key debates on synthesized cannabinoids, community reinvestment, and social equity.

After more than three years, rulemaking on pesticide testing still elicited criticism from many producers and processors, though a few stakeholders suggested enacting and moving on.

A bill requiring accuracy in CBD labeling was welcomed by hemp stakeholders, but dissent centered on definitions cribbed from another bill and whether the legislation was necessary.

With increasing incidents of cannabis retail robbery, legislation adding reporting requirements and sentencing enhancements was seen as helpful, but some argued it sidestepped bigger issues.

A hearing on social equity legislation provoked largely favorable testimony, peppered with repeated questions and comments about proposed buffer zones changes for retailers.

A joint request bill to establish an interagency cannabis lab standards team was wholeheartedly supported by representatives of the agencies which drafted the legislation.

Two visions for the future of cannabinoid regulation were presented to senators, with testimony split between a measure developed by WACA members and WSLCB request legislation.